Cholesterol,lipoproteins and atherosclerosis

Study Group, European Atherosclerosis Society. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J 1987; 8: 77-88.

Shaper AG , Pocock SJ , Walker M. , Phillips AN , Whitehead TP , MacFarlane PW Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epid Comm Health 1985 ; 39: 197-209.

Mann JI , Lewis B. , Shepherd J. et al. Blood lipid concentrations and other risk factors: distribution, prevalence and detection. Br Med J 1988; 296: 1702-1706.

Shaper AG , Pocock SJ British blood cholesterol and the American consensus. Br Med J 1985; 291: 480-81.

Slack J. Risks of ischaemic heart disease in familial hypercholesterolaemic states . Lancet 1969; ii: 1380-82.

Angard E. , Land JM , Lenihan CJ et al. Prevention of cardiovascular disease in general practice: a proposed model. Br Med J 1986;293:177-80.

Krauss RM , Burke DJ Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982; 23: 97-104.

Blanche PJ , Gong EL , Forte TM , Nichols AV Characterisation of human high density lipoproteins by gradient gel electrophoresis . Biochim Biophys Acta 1981 ; 665: 408-19.

Blankenhorn DH , Nessini SA , Johnson RL Sanmarco ME, Azen SP, Caskin-Hemphill L. Beneficial effects of combined colestipolniacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987;257:3233-40.

Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-64.

Goldstein JL , Brown MS The low density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 1977; 46: 897-930.

Ueshima H. , Iida M. , Shimamoto T. et al. Dietary intake and total serum cholesterol level: their relationship to different lifestyles in several Japanese populations. Circulation 1982; 66: 519-26.

Goldstein JL , Brown MS Familial hypercholesterolaemia: pathogenesis of a receptor disease. Johns Hopkins Med J 1978; 143: 8-16.

Slater HR , Packard CJ , Shepherd J. Receptor-independent catabolism of low density lipoprotein: involvement of the reticuloendothelial system. J Biol Chem 1982; 257:307-10.

Faggiotto A. , Ross R. , Harker L. Studies of hypercholesterolaemia in the non-human primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1984; 4: 323-40.

Goldstein JL , Ho YK , Basu JK , Brown MS Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesteryl ester deposition. Proc Natl Acad Sci USA 1979; 76: 333-37.

Henriksen T. , Mahoney EM , Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 1983; 3: 149-59.

Ross R. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis 1981; vmr-1: 293-311.

Beltz WF , Young SG , Witztum JL Heterogeneity in low density lipoprotein metabolism. In: Lippel K ed, Proceedings of the Workshop on Lipoprotein Heterogeneity, NIH Publications No. 87-2646, 1987: 215-36.

Eisenberg S. , Gavish D. , Oschry Y. , Fainaru M. , Deckelbaum RJ Abnormalities in very low, low and high density lipoproteins in hypertriglyceridaemia. Reversal toward normal with bezafibrate treatment. J Clin Invest 1984; 74: 470-82.

McLean JW , Tombinson JE , Kuang WJ et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen . Nature 1987; 300: 132-37.

Miles LA , Fless GM , Levin EG , Scanu AM , Plow EF A potential basis for the thrombotic risks associated with lipoprotein(a) . Nature 1989;338:301-303.

Houlston R. , Quiney J. , Mount J. , Watts GF , Lewis B. Lipoprotein(a) and coronary heart disease in familial hypercholesterolaemia. Lancet 1988; ii: 405.

Ütermann G. , Menzel HJ , Kraft HG , Duba HC , Kemmler HG , Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a) - lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458-65.

Karlin JB , Johnson WJ , Benedict CR , Chacko GK , Phillips MC , Rothblat GM Cholesterol flux between cells and high density lipoprotein. J Biol Chem 1987; 262: 12557-64.

Albers JJ , Tollefson JH , Chen C-H. and Steinmetz A. Isolation and characterisation of human plasma lipid transfer proteins . Arteriosclerosis 1984; 4: 49-58.

Fielding CJ , Fielding PE Regulation of human plasma lecithin: cholesteryl acyl transferase activity by lipoprotein acceptor cholesteryl ester content . J Biol Chem 1981; 256: 2102-104.

Kuusi T. , Saarinen P. , Nikkila EA Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis 1980; 36: 589-93.

Kondo I. , Berg K. , Drayna D. , Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989; 35: 49-56.

Castelli WP The triglyceride issue: a view from Framingham. Am Heart J 1986; 112: 432-37.

Frick MH , Ebo O. , Haapa K. et al. Hensinki Heart Study. Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 1987; 317: 1237-45.

Carlson LA , Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid . Acta Med Scand 1988; 223: 405-18.

Packard CJ , Shepherd J. Involvement in the hepatobiliary axis and regulation of plasma lipoprotein levels. In: Fears R , Sabine JR eds, Cholesterol 7α hydroxylase , Boca Raton: CRC Press, 1986: 148-65.

Simons LA , Dwyer T. , Simons J. et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 1987 ; 65: 181-89.

Mahley RW , Innerarity TL , Brown MS , Ho YK , Goldstein JL Cholesteryl ester synthesis in macrophages: stimulation by β-very low density lipoproteins from cholesterol fed animals of several species. J Lipid Res 1980; 970-80.

Shepherd J. , Packard CJ , Bicker S. , Lawrie Tdv , Morgan HG Cholestyramine promotes receptor-mediated low density lipoprotein catabolism. N Engl J Med 1980; 302: 1219-22.

Levy RI , Brensike JF , Epstein SE et al. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary heart disease. Circulation 1984; 69: 325-27.